L834-0675 Screening compound: 4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

L834-0675 Screening compound: 4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one
L834-0675 Screening compound: 4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L834-0675
4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L834-0675

Molecular Formula

C16H15N5O3 (C16 H15 N5 O3)

Compound Name

4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

4-ethyl-6-[5-(1-methyl-1H-pyrazol-5-yl)-124-oxadiazol-3-yl]-34-dihydro-2H-14-benzoxazin-3-one

SMILES

CCN1c(cc(cc2)-c3noc(-c4ccnn4C)n3)c2OCC1=O

InChI

InChI=1S/C16H15N5O3/c1-3-21-12-8-10(4-5-13(12)23-9-14(21)22)15-18-16(24-19-15)11-6-7-17-20(11)2/h4-8H,3,9H2,1-2H3

InChI Key

FIIXBGGAJSPXAR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478926

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

325.33

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.690

Distribution Coefficient, logD

1.690

Water Solubility, LogSw

-2.10

Polar Surface Area

69.121

Acid Dissociation Constant (pKa)

21.08

Base Dissociation Constant (pKb)

1.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

L834-0675 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

GPCR Targeted Library (31838 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L834-0675 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L834-0675?
Check Price and Availability of L834-0675, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L834-0675 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L834-0675
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L834-0675
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L834-0675 available by request